Insiders who reported open-market trades in the last 12 months at the companies Marshall S. Stanton files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
James P. Mackin - $9.72M in AORT purchases and sales in the last 12 months
Jean F. Holloway - $2.21M in AORT purchases and sales in the last 12 months
John E. Davis - $1.52M in AORT purchases and sales in the last 12 months
Andrew M. Green - $1.43M in AORT purchases and sales in the last 12 months
Lance A. Berry - $803K in AORT purchases and sales in the last 12 months
Amy Horton - $667K in AORT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Marshall S. Stanton is a corporate insider, tracked as SVP, Clinical & MD Affair of ARTIVION, INC. (AORT). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Marshall S. Stanton last file a Form 4?
The most recent primary Form 4 on record is dated 4 March 2026, one of 7 filings going back to 2025.
Has Marshall S. Stanton been buying or selling stock?
Recorded transactions: 0 open-market purchases and 10 open-market sales ($2.09M) across all tracked filings.
Marshall S. Stanton is SVP, Clinical & MD Affair of ARTIVION, INC. (AORT). 7 SEC Form 4 filings on record going back to 2025, most recently on 4 March 2026. Most recent open-market trade: sold $81K of AORT on 4 March 2026. Lifetime open-market sales: $2.09M.
Recent transactions
14
The latest 14 SEC Form 4 transactions reported by Marshall S. Stanton.
InsiderAlpha's records for Marshall S. Stanton go back to 2025: 7 primary Form 4 filings, an average of 3.5 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
